Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




AI Tool Combines Lung Screening CT with Clinical Data to Predict Lung Cancer without Radiologist Assistance

By HospiMedica International staff writers
Posted on 28 Oct 2021

A new artificial intelligence (AI)-based model that combines lung screening computed tomography (CT) information with clinical data has been shown to better predict lung cancer without the need for manual reading.

The deep learning tool built by scientists at the Vanderbilt University (Nashville, TN, USA) integrates CT features such as nodule size and risk factors including age, pack-years smoked, cancer history, among others. The scientists developed and tested the co-learning model on exams of more than 23,000 patients and found that it outperformed risk models utilizing clinical or imaging data alone, including the popular Brock model.

The scientists developed the deep learning tool by applying a five-fold cross-validation approach to data of 23,505 patients from the National Lung Screening Trial. The team used screening data from close to 150 patients in an in-house program for external testing. The scientists found that the deep learning tool notched an area under the receiver operating characteristic curve score of 0.88, which was higher than published models dependent completely on imaging data (0.86) and clinical risk factors (0.69).

More importantly, the deep learning tool automatically pulls high-risk regions from CT exams without the need for any effort by the radiologist. However, gathering clinical data does involve manual effort from radiologists and physicians. The scientists believe that their co-learning approach could be particularly beneficial as more patients start to qualify for screening exams and the insights from the tool could find low-risk individuals to be actually high-risk.

“Risk estimation among lung screening participants will become even more important with the impending expansion of screening guidelines to include those patients who are considered lower risk only based on age and history of tobacco use,” stated Riqiang Gao, a PhD student in computer science at Vanderbilt University. “The role of [the] radiologist is still irreplaceable in terms of looking for and reporting clinically significant findings (emphysema, pulmonary fibrosis, atelectasis, etc.).”

Related Links:
Vanderbilt University 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Electrocardiograph
BeneHeart R700/R900
New
Patient Monitor
Vista 300
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.